Medically Reproducing Bariatric Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

October 23, 2018

Study Completion Date

October 23, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
OTHER

OPTIFAST

OPTIFAST meal replacement includes shakes, bars and soups. These meal replacements will completely replace the subject's diet for the first 12 weeks of the study (baseline-week 12) followed by a gradual transition back to prepared meals over 6 weeks (week 13-18). Attempt will be made to reduce or eliminate Lantus and Metformin as long as glycemic control is maintained.

Trial Locations (1)

27834

Department of Veteran Affairs, Greenville Health Care Center, Greenville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Société des Produits Nestlé (SPN)

INDUSTRY

collaborator

Durham VA Medical Center

FED

collaborator

East Carolina University

OTHER

lead

Moahad S Dar

OTHER

NCT03225209 - Medically Reproducing Bariatric Surgery | Biotech Hunter | Biotech Hunter